Free Trial
→ Nobody Understands Why Trump Is Invading Iran (here’s the answer) (From Banyan Hill Publishing) (Ad)tc pixel Free KSI Stock Alerts

kneat.com (KSI) Competitors

kneat.com logo
C$4.62 +0.15 (+3.36%)
As of 04:00 PM Eastern
Compare

KSI vs. VHI, CARE, RHT, ADK, and DOC

Should you be buying kneat.com stock or one of its competitors? The main competitors of kneat.com include Vitalhub (VHI), Dialogue Health Technologies (CARE), Reliq Health Technologies (RHT), DIAGNOS (ADK), and CloudMD Software & Services (DOC). These companies are all part of the "health information services" industry.

How does kneat.com compare to Vitalhub?

Vitalhub (TSE:VHI) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Vitalhub presently has a consensus target price of C$13.86, suggesting a potential upside of 73.43%. kneat.com has a consensus target price of C$6.25, suggesting a potential upside of 35.28%. Given Vitalhub's higher possible upside, analysts plainly believe Vitalhub is more favorable than kneat.com.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vitalhub
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.14
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

Vitalhub has a beta of 0.866895, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, kneat.com has a beta of 0.861672, meaning that its stock price is 14% less volatile than the S&P 500.

Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VitalhubC$108.97M4.64C$3.35MC$0.1079.90
kneat.comC$63.26M7.02-C$8.62M-C$0.02N/A

Vitalhub has a net margin of 5.61% compared to kneat.com's net margin of -3.71%. Vitalhub's return on equity of 2.75% beat kneat.com's return on equity.

Company Net Margins Return on Equity Return on Assets
Vitalhub5.61% 2.75% 3.81%
kneat.com -3.71%-3.55%-9.84%

In the previous week, kneat.com had 3 more articles in the media than Vitalhub. MarketBeat recorded 4 mentions for kneat.com and 1 mentions for Vitalhub. kneat.com's average media sentiment score of 0.22 beat Vitalhub's score of 0.00 indicating that kneat.com is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vitalhub
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
kneat.com
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

28.8% of Vitalhub shares are held by institutional investors. Comparatively, 4.8% of kneat.com shares are held by institutional investors. 18.6% of Vitalhub shares are held by company insiders. Comparatively, 26.0% of kneat.com shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Vitalhub beats kneat.com on 11 of the 16 factors compared between the two stocks.

How does kneat.com compare to Dialogue Health Technologies?

kneat.com (TSE:KSI) and Dialogue Health Technologies (TSE:CARE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk.

kneat.com currently has a consensus price target of C$6.25, suggesting a potential upside of 35.28%. Given kneat.com's stronger consensus rating and higher possible upside, research analysts clearly believe kneat.com is more favorable than Dialogue Health Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25
Dialogue Health Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

kneat.com has higher earnings, but lower revenue than Dialogue Health Technologies. kneat.com is trading at a lower price-to-earnings ratio than Dialogue Health Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
kneat.comC$63.26M7.02-C$8.62M-C$0.02N/A
Dialogue Health TechnologiesC$95.88M0.00-C$19.50M-C$0.30N/A

4.8% of kneat.com shares are held by institutional investors. Comparatively, 47.0% of Dialogue Health Technologies shares are held by institutional investors. 26.0% of kneat.com shares are held by company insiders. Comparatively, 11.7% of Dialogue Health Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

kneat.com has a net margin of -3.71% compared to Dialogue Health Technologies' net margin of -19.73%. kneat.com's return on equity of -3.55% beat Dialogue Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
kneat.com-3.71% -3.55% -9.84%
Dialogue Health Technologies -19.73%-19.76%-10.01%

In the previous week, kneat.com had 4 more articles in the media than Dialogue Health Technologies. MarketBeat recorded 4 mentions for kneat.com and 0 mentions for Dialogue Health Technologies. kneat.com's average media sentiment score of 0.22 beat Dialogue Health Technologies' score of 0.00 indicating that kneat.com is being referred to more favorably in the media.

Company Overall Sentiment
kneat.com Neutral
Dialogue Health Technologies Neutral

kneat.com has a beta of 0.861672, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Dialogue Health Technologies has a beta of 2.66, indicating that its stock price is 166% more volatile than the S&P 500.

Summary

kneat.com beats Dialogue Health Technologies on 12 of the 16 factors compared between the two stocks.

How does kneat.com compare to Reliq Health Technologies?

Reliq Health Technologies (CVE:RHT) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Reliq Health Technologies has higher earnings, but lower revenue than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Reliq Health Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Reliq Health TechnologiesN/AN/AN/A-C$0.02N/A
kneat.comC$63.26M7.02-C$8.62M-C$0.02N/A

kneat.com has a consensus price target of C$6.25, suggesting a potential upside of 35.28%. Given kneat.com's stronger consensus rating and higher probable upside, analysts plainly believe kneat.com is more favorable than Reliq Health Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Reliq Health Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

2.8% of Reliq Health Technologies shares are owned by institutional investors. Comparatively, 4.8% of kneat.com shares are owned by institutional investors. 1.8% of Reliq Health Technologies shares are owned by insiders. Comparatively, 26.0% of kneat.com shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Reliq Health Technologies has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500. Comparatively, kneat.com has a beta of 0.861672, indicating that its stock price is 14% less volatile than the S&P 500.

In the previous week, kneat.com had 4 more articles in the media than Reliq Health Technologies. MarketBeat recorded 4 mentions for kneat.com and 0 mentions for Reliq Health Technologies. kneat.com's average media sentiment score of 0.22 beat Reliq Health Technologies' score of 0.00 indicating that kneat.com is being referred to more favorably in the news media.

Company Overall Sentiment
Reliq Health Technologies Neutral
kneat.com Neutral

kneat.com has a net margin of -3.71% compared to Reliq Health Technologies' net margin of -95.54%. kneat.com's return on equity of -3.55% beat Reliq Health Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Reliq Health Technologies-95.54% -221.64% -5.30%
kneat.com -3.71%-3.55%-9.84%

Summary

kneat.com beats Reliq Health Technologies on 11 of the 14 factors compared between the two stocks.

How does kneat.com compare to DIAGNOS?

DIAGNOS (CVE:ADK) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

kneat.com has a net margin of -3.71% compared to DIAGNOS's net margin of -6,907.32%. DIAGNOS's return on equity of 3,086.87% beat kneat.com's return on equity.

Company Net Margins Return on Equity Return on Assets
DIAGNOS-6,907.32% 3,086.87% -134.33%
kneat.com -3.71%-3.55%-9.84%

0.3% of DIAGNOS shares are held by institutional investors. Comparatively, 4.8% of kneat.com shares are held by institutional investors. 16.8% of DIAGNOS shares are held by insiders. Comparatively, 26.0% of kneat.com shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

DIAGNOS has higher earnings, but lower revenue than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than DIAGNOS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DIAGNOSC$68.16K367.49-C$3.81M-C$0.05N/A
kneat.comC$63.26M7.02-C$8.62M-C$0.02N/A

DIAGNOS has a beta of 0.173588, indicating that its share price is 83% less volatile than the S&P 500. Comparatively, kneat.com has a beta of 0.861672, indicating that its share price is 14% less volatile than the S&P 500.

kneat.com has a consensus target price of C$6.25, suggesting a potential upside of 35.28%. Given kneat.com's stronger consensus rating and higher probable upside, analysts clearly believe kneat.com is more favorable than DIAGNOS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DIAGNOS
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

In the previous week, kneat.com had 4 more articles in the media than DIAGNOS. MarketBeat recorded 4 mentions for kneat.com and 0 mentions for DIAGNOS. kneat.com's average media sentiment score of 0.22 beat DIAGNOS's score of 0.00 indicating that kneat.com is being referred to more favorably in the news media.

Company Overall Sentiment
DIAGNOS Neutral
kneat.com Neutral

Summary

kneat.com beats DIAGNOS on 13 of the 17 factors compared between the two stocks.

How does kneat.com compare to CloudMD Software & Services?

CloudMD Software & Services (CVE:DOC) and kneat.com (TSE:KSI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

kneat.com has a net margin of -3.71% compared to CloudMD Software & Services' net margin of -91.12%. kneat.com's return on equity of -3.55% beat CloudMD Software & Services' return on equity.

Company Net Margins Return on Equity Return on Assets
CloudMD Software & Services-91.12% -102.91% -8.74%
kneat.com -3.71%-3.55%-9.84%

0.5% of CloudMD Software & Services shares are held by institutional investors. Comparatively, 4.8% of kneat.com shares are held by institutional investors. 0.1% of CloudMD Software & Services shares are held by company insiders. Comparatively, 26.0% of kneat.com shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

kneat.com has lower revenue, but higher earnings than CloudMD Software & Services. kneat.com is trading at a lower price-to-earnings ratio than CloudMD Software & Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CloudMD Software & ServicesC$90.91M0.12-C$76.56M-C$0.23N/A
kneat.comC$63.26M7.02-C$8.62M-C$0.02N/A

CloudMD Software & Services has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, kneat.com has a beta of 0.861672, indicating that its stock price is 14% less volatile than the S&P 500.

kneat.com has a consensus target price of C$6.25, suggesting a potential upside of 35.28%. Given kneat.com's stronger consensus rating and higher possible upside, analysts clearly believe kneat.com is more favorable than CloudMD Software & Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CloudMD Software & Services
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
kneat.com
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.25

In the previous week, kneat.com had 4 more articles in the media than CloudMD Software & Services. MarketBeat recorded 4 mentions for kneat.com and 0 mentions for CloudMD Software & Services. kneat.com's average media sentiment score of 0.22 beat CloudMD Software & Services' score of 0.00 indicating that kneat.com is being referred to more favorably in the news media.

Company Overall Sentiment
CloudMD Software & Services Neutral
kneat.com Neutral

Summary

kneat.com beats CloudMD Software & Services on 13 of the 17 factors compared between the two stocks.

Get kneat.com News Delivered to You Automatically

Sign up to receive the latest news and ratings for KSI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KSI vs. The Competition

Export
Metrickneat.comHealth Information Services IndustryMedical SectorTSE Exchange
Market CapC$444.13MC$310.86MC$6.25BC$11.72B
Dividend YieldN/A5.59%2.73%6.22%
P/E Ratio-231.00194.8029.0423.83
Price / Sales7.02124.62476.6113.46
Price / Cash13.1847.1427.6282.69
Price / Book6.795.319.674.48
Net Income-C$8.62M-C$22.78MC$3.55BC$300.68M
7 Day Performance5.72%0.52%1.70%0.12%
1 Month Performance27.62%3.12%5.62%2.88%
1 Year Performance-28.92%-7.88%34.42%57.78%

kneat.com Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KSI
kneat.com
2.0627 of 5 stars		C$4.62
+3.4%		C$6.25
+35.3%		N/AC$444.13MC$63.26MN/A293
VHI
Vitalhub
3.0291 of 5 stars		C$8.02
-1.0%		C$13.86
+72.8%		N/AC$507.12MC$108.97M80.202,250
CARE
Dialogue Health Technologies
N/AN/AN/AN/AC$345.36MC$95.88MN/A730
RHT
Reliq Health Technologies
N/AC$0.22
flat		N/AN/AC$46.65MN/AN/A12,600
ADK
DIAGNOS
N/AC$0.24
flat		N/AN/AC$28.03MC$68.16KN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:KSI) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel